Natera Drops Appeal in Patent Dispute With NeoGenomics

Natera, Inc. +2.35%
NeoGenomics, Inc. +3.23%

Natera, Inc.

NTRA

207.98

+2.35%

NeoGenomics, Inc.

NEO

8.00

+3.23%

NeoGenomics Inc. announced that Natera has voluntarily withdrawn its appeal in the ongoing RaDaR patent litigation. This decision follows a North Carolina District Court ruling in August 2025 that favored NeoGenomics, granting summary judgment and declaring Natera's asserted patent claims invalid for ineligible subject matter. As a result, Natera's claims against NeoGenomics were dismissed with prejudice, and a declaratory judgment of invalidity was entered for both of Natera's asserted patents. The conclusion of this litigation allows NeoGenomics to focus on the clinical launch of its RaDaR ST product in the first quarter of next year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NeoGenomics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251215508360) on December 15, 2025, and is solely responsible for the information contained therein.
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.